Updated Date:
16 Oct 2026
Product Detail:
TYKERB lapatinib 250mg (as ditosilate monohydrate) tablet bottle
Shortage Status:
Anticipated
AUST R:
185997
Availability:
Available
Active Ingredient:
lapatinib ditosilate monohydrate
Reason:
Manufacturing
Dosage Form:
Tablet,filmcoated
Supply Impact Dates
From 25 Oct 2026
To 01 Dec 2026
Management Action:
An overseas registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals